Attached files

file filename
EX-32.2 - SECTION 906 CERTIFICATION OF PFO - Feihe International Incv221690_ex32-2.htm
EX-31.1 - SECTION 302 CERTIFICATION OF PEO - Feihe International Incv221690_ex31-1.htm
EX-31.2 - SECTION 302 CERTIFICATION OF PFO - Feihe International Incv221690_ex31-2.htm
EX-32.1 - SECTION 906 CERTIFICATION OF PEO - Feihe International Incv221690_ex32-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2011
 
Or
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from __________ to __________
 
Commission File Number 001-32473

FEIHE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)

Utah
 
90-0208758
(State or other jurisdiction of
 incorporation or organization)
 
(I.R.S. Employer
Identification No.)

Star City International Building, 10 Jiuxianqiao Road, C-16th Floor
Chaoyang District, Beijing, China, 100016
(Address of principal executive offices, including zip code)

+86 (10) 8457-4688
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x     No  ¨

Indicate by check mark whether the registrant  has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  ¨     No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer    ¨
 
Accelerated filer  x
Non-accelerated filer      ¨  (Do not check if a smaller reporting company)
 
Smaller reporting company  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x

The number of shares outstanding of the registrant’s common stock as of May 6, 2011 was 22,306,291.

 
 

 

FEIHE INTERNATIONAL, INC.

FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, 2011

 TABLE OF CONTENTS
 
PART I — FINANCIAL INFORMATION
   
   
     
Item 1.
Condensed Consolidated Financial Statements  
3
   
     
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations  
25
   
     
Item 3.
 Quantitative and Qualitative Disclosures About Market Risk  
33
   
     
Item 4.
Controls and Procedures  
34
   
     
PART II — OTHER INFORMATION
   
   
     
Item 5.
Other Information   36
       
Item 6.
Exhibits  
36
       
SIGNATURES
 
37
   
     
EXHIBIT INDEX
 
 

Unless the context otherwise requires, the terms “we,” “us,” “our,” “Feihe International,” and “the Company” refer to Feihe International, Inc., a Utah corporation, and its consolidated subsidiaries.  References to “dollars” and “$” are to United States dollars.
 
 
2

 
 
PART I — FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

FEIHE INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)

   
March 31,
2011
 
December 31,
2010
 
   
US$
 
US$
 
Assets
         
Current assets:
         
Cash and cash equivalents
    19,097,434       17,529,582  
Restricted cash
    264,447       3,078,564  
Notes and loans receivable, net of allowance for doubtful accounts of $3,350,056 and $3,500,028, as of March 31, 2011 and December 31, 2010, respectively
    -       136,120  
Trade receivables, net of allowance for doubtful accounts of $1,600,560 and $1,084,308, as of March 31, 2011 and December 31, 2010, respectively
    18,603,129       15,885,708  
Due from related parties
    1,795,240       1,806,889  
Advances to suppliers
    12,435,923       7,520,804  
Inventories
    62,399,998       71,683,471  
Prepayments and other current assets
    166,055       266,935  
Income taxes receivable
    3,615,068       4,970,271  
Input value-added taxes
    3,134,056       6,886,531  
Other receivables
    16,425,641       7,275,903  
Investment in mutual funds – available-for-sale
    137,944       139,294  
Total current assets
    138,074,935       137,180,072  
                 
Investments:
               
Investment at cost
    274,879       272,239  
                 
Property, plant and equipment:
               
Property, plant and equipment, net
    171,309,921       170,354,132  
Construction in progress
    43,507,177       43,152,905  
      214,817,098       213,507,037  
Biological assets:
               
Immature biological assets
    21,681,136       26,713,971  
Mature biological assets, net
    32,319,172       27,683,821  
      54,000,308       54,397,792   
                 
Other assets:
               
Advance to suppliers – non-current
    19,709,635       22,643,263  
Deferred tax assets – non-current
    5,522,990       5,522,990  
Prepaid leases for land use rights
    29,857,746       29,754,376  
Other intangible assets, net
    542,613       585,671  
Goodwill
    474,821       445,842  
Total assets
    463,275,025       464,309,282  
                 
Liabilities
               
Current liabilities:
               
Notes payable
    -       378,112  
Short term bank loans
    69,483,683       68,816,359  
Accounts payable
    38,338,543       43,729,571  
Accrued expenses
    1,827,814       6,436,898  
Income tax payable
    507,258       1,589,165  
Advances from customers
    17,928,118       12,183,444  
Due to related parties
    89,481       79,257  
Advances from employees
    406,166       456,261  
Employee benefits and salary payable
    6,442,134       7,018,794  
Other payable
    42,527,135       45,957,104  
Current portion of long term bank loans
    10,985,643       9,756,193  
Current portion of capital lease obligation
    157,646       116,770  
Redeemable common stock (US$0.001 par value, 2,625,000 shares issued and outstanding as of March 31, 2011)
    65,079,979       -  
Total current liabilities
    253,773,600       196,517,928  
                 
Long term bank loans, net of current portion
    27,240,461       28,102,786  
Capital lease obligation, net of current portion
    506,589       532,467  
Unrecognized tax benefits – non-current
    5,254,327       5,062,336  
Deferred income
    6,288,123       6,241,661  
Total liabilities
    293,063,100       236,457,178  
                 
Commitments and contingencies (see Note 19)
               
                 
Redeemable common stock (US$0.001 par value, 2,625,000 shares issued and outstanding as of December 31, 2010)
    -       66,113,715  
                 
Equity
               
Feihe International, Inc. shareholders’ equity:
               
Common stock (US$0.001 par value, 50,000,000 shares authorized; 19,671,291 shares issued and outstanding as of March 31, 2011 and December 31, 2010, respectively)
    19,671       19,671  
Additional paid-in capital
    57,579,834       57,177,680  
Common stock warrants
    1,774,151       1,774,151  
Statutory reserves
    9,132,581       9,132,581  
Accumulated other comprehensive income
    35,152,882       32,836,344  
Retained earnings
    66,461,441       60,731,029  
Total Feihe International, Inc. shareholders’ equity
    170,120,560       161,671,456  
Noncontrolling interests
    91,365       66,933  
                 
Total equity
    170,211,925       161,738,389  
                 
Total liabilities, redeemable common stock and equity
    463,275,025       464,309,282  
 
The accompanying notes are an integral part of these financial statements.

 
3

 

FEIHE INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

   
Three months ended 
March 31,
 
   
2011
   
2010
 
   
US$
   
US$
 
Sales
   
76,449,422
     
81,435,903
 
                 
Cost of goods sold
   
(48,578,176
   
(42,998,182
                 
Gross profit
   
27,871,246
     
38,437,721
 
                 
Operating expenses:
               
Sales and marketing
   
(16,170,266
   
(28,281,824
General and administrative
   
(6,229,148
   
(5,493,823
Loss on disposal of biological assets
   
(1,601,685
)
   
(2,785,262
)
Total operating expenses
   
(24,001,099
   
(36,560,909
                 
Other operating income, net
   
2,093,580
     
208,682
 
Operating income
   
5,963,727
     
2,085,494
 
                 
Other income (expenses):
               
Interest income
   
22,428
     
97,636
 
Interest and finance costs
   
(1,439,080
   
(864,183
)
Government subsidy
   
1,534,151
     
5,738,773
 
Income before income taxes
   
6,081,226
     
7,057,720
 
                 
Income tax expenses
   
(1,341,683
   
(1,585,817
Net income
   
4,739,543
     
5,471,903
 
Net income (loss) attributable to noncontrolling interests
   
(42,867
   
61,693
 
Net income attributable to common shareholders of Feihe International, Inc.
   
4,696,676
     
5,533,596
 
                 
Net income per share of common stock
               
Basic
   
0.26
     
0.25
 
Diluted
   
0.26
     
0.25
 
Net income per share of  redeemable common stock
               
Basic
   
0.21
     
 0.24
 
Diluted
   
0.21
     
0.24
 
Weighted average shares used in calculating net income per share of common stock
               
Basic
   
19,671,291
     
19,607,376
 
Diluted
   
19,689,849
     
20,054,189
 
Weighted average shares used in calculating net income per share of redeemable common stock
               
Basic
   
2,625,000
     
2,625,000
 
Diluted
   
2,625,000
     
2,625,000
 
 
The accompanying notes are an integral part of these financial statements.

 
4

 


 
FEIHE INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND COMPREHENSIVE INCOME (LOSS)
(unaudited)
 
   
Feihe International, Inc. Shareholders
                   
   
Common Stock
                                                 
   
(US$0.001 par value)
                     
Accumulated
                         
   
Number
of
Shares
   
Par
Value
   
Additional
Paid-in
Capital
   
Common
Stock
Warrants
   
Statutory
Reserves
   
Other
Comprehensive
Income
   
Retained
Earnings
   
Noncontrolling
Interests
   
Total
Equity
   
Total
Comprehensive
Income (Loss)
 
         
US$
   
US$
   
US$
   
US$
   
US$
   
US$
   
US$
   
US$
   
US$
 
Balance as of January 1, 2011
   
19,671,291
     
19,671
     
57,177,680
     
1,774,151
     
9,132,581
     
32,836,344
     
60,731,029
     
66,933
     
161,738,389
       
Share-based compensation
   
     
     
402,154
     
     
     
     
     
     
402,154
       
Net income
   
     
     
     
     
     
     
4,696,676
     
42,867
     
4,739,543
     
4,739,543
 
Currency translation adjustments
   
     
     
     
     
     
2,317,888
     
     
(18,435
   
2,299,453
     
2,299,453
 
Change in fair value of available for sale investments, net of tax $(400)
   
     
     
     
     
     
(1,350
   
     
     
(1,350
)
   
(1,350
Comprehensive income
                                                                           
7,037,646
 
Settlement of  redeemable common stock
   
     
     
     
     
     
     
1,033,736
     
     
1,033,736
         
                                                                                 
Balance as of March 31, 2011
   
19,671,291
     
19,671
     
57,579,834
     
1,774,151
     
9,132,581
     
35,152,882
     
66,461,441
     
91,365
     
170,211,925
         
 
   
Feihe International, Inc. Shareholders
                   
   
Common Stock
                                                 
   
(US$0.001 par value)
                     
Accumulated
                         
   
Number
of
Shares
   
Par
Value
   
Additional
Paid-in
Capital
   
Common
Stock
Warrants
   
Statutory
Reserves
   
Other
Comprehensive
Income
   
Retained
Earnings
   
Noncontrolling
Interests
   
Total
Equity
   
Total
Comprehensive
Income (Loss)
 
         
US$
   
US$
   
US$
   
US$
   
US$
   
US$
   
US$
   
US$
   
US$
 
Balance as of January 1, 2010
   
19,607,376
     
19,607
     
54,482,098
     
1,774,151
     
6,861,224
     
25,651,571
     
73,672,879
     
345,451
     
162,806,981
       
Share-based compensation
   
     
     
952,954
     
     
     
     
     
     
952,954
       
Net income
   
     
     
     
     
     
     
5,533,596
     
(61,693
)
   
5,471,903
     
5,471,903
 
Currency translation adjustments
   
     
     
     
     
     
(34,453
   
     
(124
   
(34,577
   
(34,577
Change in fair value of available for sale investments, net of tax $(2,262)
   
     
     
     
     
     
(9,050
   
     
     
(9,050
)
   
(9,050
Comprehensive income
                                                                           
5,428,276
 
Investment in a new subsidiary
   
     
     
     
     
     
     
     
219,372
     
219,372
         
                                                                                 
Balance as of March 31, 2010
   
19,607,376
     
19,607
     
55,435,052
     
1,774,151
     
6,861,224
     
25,608,068
     
79,206,475
     
503,006
     
169,407,583
         
 
The accompanying notes are an integral part of these financial statements.
 
 
5

 

FEIHE INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)

   
Three months ended March 31,
 
   
2011
   
2010
 
   
US$
   
US$
 
Cash flows from operating activities:
           
Net income
   
4,739,543
     
5,471,903
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
   
2,208,279
     
2,146,187
 
Depreciation of biological assets
   
1,691,195
     
689,091
 
Amortization of capital lease obligation
   
8,702
     
9,760
 
Loss (gain) on disposal of property, plant and equipment
   
21,754
     
(3,632
Loss on disposal of biological assets
   
1,601,685
     
2,785,262
 
Provision for (reversal of) doubtful accounts
   
503,431
     
(261,959
)
Compensation expense for option awards
   
402,154
     
952,954
 
Amortization of deferred charges
   
-
     
19,320
 
                 
Changes in assets and liabilities:
               
(Increase) decrease in trade receivables, net
   
(3,040,911
   
3,516,103
 
Decrease (increase) in due from related parties
   
10,998
     
(812,497
Decrease (increase) in inventories, net
   
8,720,952
     
(164,530
(Increase) decrease in advances to suppliers
   
(4,640,524
   
42,972
 
Decrease in prepayments and other assets
   
95,244
     
1,634,818
 
Decrease in income taxes receivable
   
1,279,492
     
110,438
 
Decrease in input value-added taxes
   
3,542,834
     
1,892,571
 
Increase in other receivables
   
(5,930,037
)
   
(1,464
Decrease in notes receivable
   
128,516
     
246,310
 
Decrease in notes payable
   
(356,988
)
   
(3,020,764
)
(Decrease) increase in accrued expenses
   
(4,351,587
)
   
7,008,521
 
Decrease in accounts payable
   
(3,786,668
   
(1,485,880
)
(Decrease) increase in income taxes payable
   
(1,021,463
   
1,286,309
 
Increase in advances from customers
   
5,423,735
     
1,572,295
 
Increase (decrease) in due to related parties
   
9,653
     
(15,682
Decrease in advances from employees
   
(47,295
)
   
(20,348
(Decrease) increase in employment benefits and salary payable
   
(544,447
)
   
189,052
 
(Decrease) increase in other payable
   
(3,143,836
   
587,596
 
Decrease in deferred income
   
-
     
(1,590,848
)
Increase in unrecognized tax benefits– non-current
   
181,261
     
156,165
 
Net cash provided by operating activities
   
3,705,672
     
22,940,023
 
                 
Cash flows from investing activities:
               
Purchase of property, plant and equipment
   
(2,042,456
)
   
(4,584,943
Purchase of biological assets
   
(3,447,062
)
   
(3,422,638
Purchase of short term investment
   
-
     
(1,462,822
Proceeds from disposal of property, plant and equipment
   
-
     
32,182
 
Change in restricted cash
   
2,831,001
     
(9,338,110
Proceeds from disposal of biological assets
   
340,046
     
420,997
 
Net cash used in investing activities
   
(2,318,471
)
   
(18,355,334
                 
Cash flows from financing activities:
               
Proceeds from short term bank loans
   
1,367,490
     
2,340,516
 
Repayment of short term bank loans
   
(1,362,728
)
   
(9,625,371
Capital injection in a new subsidiary by noncontrolling interests
   
-
     
219,372
 
Net cash provided by (used in) financing activities
   
4,762
     
(7,065,483
                 
Effect of exchange rate changes on cash
   
175,889
     
48,913
 
                 
Net increase (decrease) in cash and cash equivalents
   
1,567,852
     
(2,431,881
Cash and cash equivalents, beginning of period
   
17,529,582
     
48,164,932
 
Cash and cash equivalents, end of period
   
19,097,434
     
45,733,051
 
                 
Supplemental disclosure of cash flow information:
               
Cash paid during the period for income tax
   
(854,550
)
   
(111,177
Cash received during the period for tax refund
   
-
     
3,437,633
 
Interest paid during the period
   
(1,663,350
)
   
(1,396,154
                 
Supplemental disclosure of non-cash investing and financing activities:
               
Issuance of performance shares of common stock
   
-
     
11,382,000
 

The accompanying notes are an integral part of these financial statements.
 
 
6

 
 
FEIHE INTERNATIONAL, INC
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

1. ORGANIZATION AND NATURE OF OPERATION

The accompanying consolidated financial statements include the financial statements of Feihe International, Inc., formerly known as American Dairy, Inc. (the “Company,” “Feihe International,” “we,” “us” and “our”) and its subsidiaries. The Company and its subsidiaries are collectively referred to as the “Group.” All of the Group's operations are conducted in the People's Republic of China.

The core activities of subsidiaries included in the condensed consolidated financial statements are as follows:

 
American Flying Crane Corporation – Investment holding

 
Langfang Flying Crane Dairy Products Co., Limited ("Langfang Feihe") – Packaging and distributing dairy products
 
 
Gannan Flying Crane Dairy Products Co., Limited (“Gannan Feihe”) – Manufacturing dairy products

 
Heilongjiang Feihe Dairy Co., Limited (“Feihe Dairy”) – Manufacturing and distributing dairy products
 
 
Baiquan Feihe Dairy Co., Limited – Manufacturing dairy products

 
Beijing Feihe Biotechnology Scientific and Commercial Co., Limited – Marketing and distributing dairy products
 
 
Shanxi Feihesantai Biotechnology Scientific and Commercial Co., Limited (“Shanxi Feihe”) – Manufacturing and distributing walnut products

 
Heilongjiang Feihe Kedong Feedlots Co., Limited ("Kedong Farms") – Breeding and rearing of dairy cows, and distributing fresh milk
 
 
Heilongjiang Feihe Gannan Feedlots Co., Limited ("Gannan Farms")  – Breeding and rearing of dairy cows, and distributing fresh milk

 
Qiqihaer Feihe Soybean Co., Limited ("Feihe Soybean")– Manufacturing and distributing soybean products
 
 
Heilongjiang Aiyingquan International Trading Co., Limited – Marketing and distributing water and cheese, specifically marketed for consumption by children

 
Heilongjiang Flying Crane Trading Co., Limited (“Feihe Trading”) – Distributing of milk and soybean related products. The subsidiary was registered in Heilongjiang province, China on January 22, 2010. The Group holds an 85% equity interest in the RMB 10,000,000 (or approximately $1.5 million) total paid-in capital of Heilongjiang Flying Crane Trading Co., Limited.

 
7

 

2. BASIS OF PREPARATION

The accompanying unaudited condensed consolidated financial statements of the Group have been prepared by the Group in accordance with the rules and regulations of the Securities and Exchange Commission (the "SEC") and the accounting principles generally accepted in the United States of America ("US GAAP") for interim reporting. In the opinion of the Group’s management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal and recurring adjustments) necessary to present fairly its financial position and the results of its operations and cash flows.  These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto filed with the SEC on Form 10-K, as amended, for the year ended December 31, 2010.  The interim operating results are not necessarily indicative of the results to be expected for an entire year.

As of March 31, 2011, the Group had a working capital deficit of $115,698,665. The Group has significant cash commitments in the next 12 months, including maturity of short term loans of approximately $69.5 million and redemption of redeemable common stock of $65 million. However, the Group believes it will be able to refinance much of its short term bank loans when they become due and intends to do so. In the first quarter of 2011, the Group refinanced a short term bank loan with its respective bank upon the maturity of that bank loan. If the Group is able to continue refinancing short-term bank loans, it believes that cash generated from operations, along with the existing cash and the ability to draw down on unutilized credit lines will be sufficient to fund its expected cash flow requirements including the cash payments for the redemption of its redeemable common stock and planned capital expenditures for at least the next 12 months. The Group expects to realize its assets and satisfy its liabilities in the normal course of business. As a result, the accompanying condensed consolidated financial statements have been prepared assuming the Group will continue as a going concern. The accompanying condensed consolidated financial statements do not reflect any adjustments relating to the recoverability and reclassification of assets and liabilities as that might be necessary if the Group is unable to continue as a going concern.
 
For the period ended March 31, 2011, the Group has used the same significant accounting policies and estimates which are discussed in the Annual Report on Form 10-K, as amended, for the year ended December 31, 2010, except for the following recently adopted accounting pronouncements. 

In January 2010, the FASB issued authoritative guidance to improve disclosures about fair value measurements. This guidance amends previous guidance on fair value measurements to add new requirements for disclosures about transfers into and out of Levels 1 and 2 and separate disclosures about purchases, sales, issuances, and settlements relating to Level 3 measurement on a gross basis rather than on a net basis as currently required. This guidance also clarifies existing fair value disclosures about the level of disaggregation and about inputs and valuation techniques used to measure fair value. This guidance is effective for annual and interim periods beginning after December 15, 2009, except for the requirement to provide the Level 3 activities of purchases, sales, issuances, and settlements on a gross basis, which will be effective for annual and interim periods beginning after December 15, 2010. Early application is permitted and, in the period of initial adoption, entities are not required to provide the amended disclosures for any previous periods presented for comparative purposes. The adoption of this guidance did not have a significant impact on the Group’s financial statements.

In July 2010, the FASB issued an authoritative pronouncement on disclosure about the credit quality of financing receivables and the allowance for credit losses. The objective of this guidance is to provide financial statement users with greater transparency about an entity’s allowance for credit losses and the credit quality of its financing receivables. The guidance requires an entity to provide disclosures on a disaggregated basis on two defined levels: (1) portfolio segment; and (2) class of financing receivable. The guidance includes additional disclosure requirements about financing receivables, including: (1) credit quality indicators of financing receivables at the end of the reporting period by class of financing receivables; (2) the aging of past due financing receivables at the end of the reporting period by class of financing receivables; and (3) the nature and extent of troubled debt restructurings that occurred during the period by class of financing receivables and their effect on the allowance for credit losses. The disclosures as of the end of a reporting period are effective for interim and annual reporting periods ending on or after December 15, 2010. The disclosures about activity that occurs during a reporting period are effective for interim and annual reporting periods beginning on or after December 15, 2010. In January 2011, the FASB issued another authoritative pronouncement that temporarily defers the effective date for disclosures about troubled debt restructurings (TDRs) by creditors until it finalizes its project on determining what constitutes a TDR for a creditor. The deferral in this amendment is effective upon issuance. The deferred TDR disclosures were slated to be effective in the first quarter of 2011 for public companies with calendar year-ends. The Company is in the process of evaluating what effect the adoption of this pronouncement will have on the Group’s financial statements.
 
 
8

 
 
In December 2010, the FASB issued an authoritative pronouncement on when to perform Step 2 of the goodwill impairment test for reporting units with zero or negative carrying amounts. The amendments in this update modify Step 1 so that for those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The qualitative factors are consistent with existing guidance, which requires that goodwill of a reporting unit be tested for impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The guidance is effective for impairment tests performed during entities’ fiscal years (and interim periods within those years) that begin after December 15, 2010. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Group’s financial statements.

In December 2010, the FASB issued an authoritative pronouncement on disclosure of supplementary pro forma information for business combinations. The objective of this guidance is to address diversity in practice regarding the interpretation of the pro forma revenue and earnings disclosure requirements for business combinations. The amendments in this update specify that if a public entity presents comparative financial statements, the entity should disclose revenue and earnings of the combined entity as though the business combination(s) that occurred during the current year had occurred as of the beginning of the comparable prior annual reporting period only. The amendments also expand the supplemental pro forma disclosures to include a description of the nature and amount of material, nonrecurring pro forma adjustments directly attributable to the business combination included in the reported pro forma revenue and earnings. The amendments will be effective for business combinations consummated in periods beginning after December 15, 2010, and should be applied prospectively as of the date of adoption. Early adoption is permitted. The adoption of the authoritative guidance did not have a material impact on the Group’s financial statements. 

3. TAXATION

The Company is subject to U.S. federal and state income taxes, and the Company’s subsidiaries incorporated in the People’s Republic of China (the “PRC”) are subject to enterprise income taxes in the PRC. 

During the three months ended March 31, 2011, the Company recorded an income tax expense of approximately $1.3 million, which was primarily due to the decrease in profits of Gannan Feihe when compared to the three months ended March 31, 2010.
  
The Company had cumulatively accrued approximately $1.8 million and $1.2 million for estimated interest and penalties related to uncertain tax positions as of March 31, 2011 and 2010, respectively. For the three months ended March 31, 2011 and 2010, the Company recorded estimated interest and penalties of approximately $0.16 million and $0.15 million, respectively.

Aggregate undistributed earnings of approximately $128.9 million as of March 31, 2011 of the Group's PRC subsidiaries that are available for distribution to the Company are considered to be indefinitely reinvested, and, accordingly, no provision has been made for the Chinese dividend withholding taxes that would be payable upon distribution to the Company. Additionally, the Chinese tax authorities have clarified that distributions made out of pre-January 1, 2008 retained earnings would not be subject to the withholding tax.

 
9

 
 
The Company's tax years from 2005 to 2010 remain open in various jurisdictions.
 
4. EARNINGS PER SHARE OF COMMON STOCK

The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations:

     
For the three months ended
March 31,
 
     
2011
     
2010
 
Net income attributable to Feihe International, Inc.
   
4,696,676
     
5,533,596
 
Net income attributable to Feihe International, Inc. allocated for computing net income per common share - Basic
   
4,143,724
     
4,880,239
 
Settlement of redeemable common stock
   
1,033,736
     
-
 
Net income attributable to Feihe International, Inc. for computing net income per common share - Basic
   
5,177,460
     
4,880,239
 
Net income attributable to Feihe International, Inc. allocated for computing net income per redeemable common stock - Basic
   
552,952
     
653,357
 
Net income attributable to Feihe International, Inc. allocated for computing net income per common share - Diluted
    4,144,184       4,893,111  
Settlement of redeemable common stock
    1,033,736       -  
Net income attributable to Feihe International, Inc. for computing net income per share of common stock - Diluted
   
5,177,920
     
4,893,111
 
Net income attributable to Feihe International, Inc. allocated for computing net income per share of redeemable common stock - Diluted
   
552,492
     
640,485
 
                 
Weighted-average common stock outstanding used in computing net income per share of common stock – Basic
   
19,671,291
     
19,607,376
 
Weighted-average common stock outstanding used in computing net income per share of common stock – Diluted (i)
   
19,689,849
     
20,054,189
 
Weighted average shares of redeemable common stock outstanding used in computing net income per share of redeemable common stock – Basic
   
2,625,000
     
2,625,000
 
Weighted average shares of redeemable common stock outstanding used in computing net income per share of redeemable common stock – Diluted
   
2,625,000
     
2,625,000
 
                 
Net income per share of common stock –
               
Basic
   
0.26
     
0.25
 
Diluted
   
0.26
     
0.25
 
                 
Net income per share of redeemable common stock –
               
Basic
   
0.21
     
0.24
 
Diluted
   
0.21
     
0.24
 
 

(i)
The following table sets forth the computation of weighted-average shares outstanding for calculating basic and diluted earnings per share for the three months ended March 31, 2011 and 2010:
 
   
   
Three months ended
 March 31,
   
   
2011
   
2010
 
Weighted-average shares – Basic
   
19,671,291
     
19,607,376
 
Effect of dilutive securities
               
  Stock option
   
18,558
     
360,173
 
  Warrants
   
-
     
86,640
 
Weighted-average shares – Diluted
   
19,689,849
     
20,054,189
 

For the three months ended March 31, 2011, 650,245 shares of the Company’s stock option and 237,937 warrants were excluded from the calculation of diluted income per share because their anti-dilutive effects.
 
 
10

 
 
5. RESTRICTED CASH

Restricted cash consists of bank demand deposits for letters of credit. This instrument is mainly used by the Group for the purchase of imported dairy cows and whey powder.

6. ADVANCES TO SUPPLIERS

Advances to suppliers consist primarily of advance for purchase of dairy cows, as well as advances for inventories and equipment, not delivered at the balance sheets date.  The Group utilizes advances to suppliers in an effort to keep future purchasing prices stable and consistent.

Advanced amounts are refundable if the transaction is not completed by the other party in accordance with the terms of the contract or agreement.  During the three month periods ended March 31, 2011 and March 31, 2010, no advances to suppliers were refunded in cash, and the Group has a minimal refund history.

7. INVENTORIES, NET

The inventory amounts included in the condensed consolidated balance sheets as of March 31, 2011 and December 31, 2010 comprised the following:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Raw materials
   
19,825,682
     
27,983,563
 
Work-in-progress
   
35,548,349
     
37,400,104
 
Finished goods
   
7,025,967
     
6,299,804
 
Total inventories, net
   
62,399,998
     
71,683,471
 

8. INVESTMENT IN MUTUAL FUNDS – AVAILABLE-FOR-SALE

The Group had the following investment measured at fair value as of the dates indicated:

   
US$
 
Balance as of December 31, 2010
   
139,294
 
Change in fair value
   
(1,350
)
Balance as of March 31, 2011
   
137,944
 
 
 
11

 
 
The cost of the investment is $190,889, with fair value measured according to quoted prices in active markets of identical assets (Level 1, which is based upon quoted prices in active markets for identical assets and liabilities).

9. CONSTRUCTION IN PROGRESS

Construction in progress included in the condensed consolidated balance sheets as of March 31, 2011 and December 31, 2010 comprised of the following:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Gannan Feihe production factory facilities
   
41,173,677
     
39,208,398
 
Gannan Farms facilities
   
676,270
     
1,326,026
 
Kedong Farms facilities
   
1,159,004
     
1,260,399
 
Feihe Soybean processing facilities
   
476,690
     
1,333,098
 
Others
   
21,536
     
24,984
 
Total
   
43,507,177
     
43,152,905
 

$266,696 and $250,339 of interest expenses were capitalized in construction in progress for the three months ended March 31, 2011 and 2010, respectively.

10. OTHER INTANGIBLE ASSETS, NET

Other intangible assets, net as of March 31, 2011 and December 31, 2010 represent the Group’s exclusive right of milk supply.

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Exclusive right of milk supply
   
542,613
     
585,671
 
 
Amortization expense for the three months ended March 31, 2011 and 2010 was $48,674 and $97,886, respectively.

Exclusive rights of milk supply, which the Group acquired in 2009, are carried at cost less accumulated amortization. Amortization is calculated on a straight-line basis over the expected useful lives of 4.7 years.  Amortization expense of intangible assets is estimated to be approximately $195,000, $195,000, $195,000, and $6,000 for 2011, 2012, 2013, and 2014, respectively.
 
 
12

 
 
11. SHORT TERM BANK LOANS

Short term bank loans included in the condensed consolidated balance sheets as of March 31, 2011 and December 31, 2010 comprised of the following:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Loan payable to a bank in the PRC, bearing interest at 5.31% per annum,  secured by machinery, payable with interest on maturity, due on January 17, 2011
   
-
     
1,361,203 
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.31% per annum,  payable with interest on maturity, due on July 25, 2011 (i)
   
7,635,570
     
7,562,237
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.31% per annum, payable with interest on maturity, due on August 30, 2011 (iv)
   
3,054,228
     
3,024,895
 
                 
 Loan payable to a bank in the PRC, bearing interest at 5.31% per annum, payable with interest on maturity, due on September 7, 2011 (iii)
   
7,635,570
     
7,562,237 
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.31% per annum, payable with interest on maturity, due on September 14, 2011 (ii)
   
5,344,899
     
5,293,566
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.31% per annum,  payable with interest on maturity, due on September 27, 2011 (iv)
   
1,527,114
     
1,512,447
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.56% per annum, payable with interest on maturity, due on October 26, 2011(iv)
   
3,054,228
     
3,024,895
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.56% per annum, payable with interest on maturity, due on November 7, 2011
   
23,975,688
     
23,745,426
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.56% per annum, secured by plant and land use right, payable with interest on maturity, due on November 7, 2011
   
6,566,590
     
6,503,524
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.56% per annum, secured by machinery, payable with interest on maturity, due on November 17, 2011
   
1,374,402
     
1,361,203
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.56% per annum, secured by machinery, payable with interest on maturity, due on December 23, 2011
   
3,970,496
     
3,932,363
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.56% per annum, payable with interest on maturity, due on December 23, 2011
   
3,970,496
     
3,932,363
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.56% per annum,  secured by machinery, payable with interest on maturity, due on January 25, 2012
   
1,374,402
     
-
 
Total
   
69,483,683
     
68,816,359
 
 

(i)
Gannan Feihe guaranteed the loans payable to a bank in the PRC for a period, beginning on July 26, 2010 and ending on the date which is two years after the maturity date or the date of repayment if earlier.
 
(ii)
Feihe Dairy guaranteed the loans payable to a bank in the PRC for a period of one year, beginning on September 15, 2010 and ending on September 14, 2011. The maximum potential future payment amount under the terms of the guarantee is RMB 35,000,000 (approximately $5,345,000) as of March 31, 2011.
 
(iii)
Gannan Feihe guaranteed the loans payable to a bank in the PRC for a period, beginning on September 7, 2010 and ending on the date which is two years after the maturity date or the date of repayment if earlier.
        
(iv)
Feihe Dairy guaranteed the loans payable to a bank in the PRC for a period of two years, beginning on August 30, 2010 and ending on August 30, 2012. The maximum potential future payment amount under the terms of the guarantee is RMB 50,000,000 (approximately $7,636,000) as of March 31, 2011.
        
 
13

 
 
All of the short term bank loans are denominated in RMB and therefore subject to exchange rate fluctuations and none of them have restrictions or covenants attached.

12. ACCRUED EXPENSES

Accrued expenses as of March 31, 2011 and December 31, 2010 consisted of the following:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Accrued selling expenses
   
1,263,557
     
5,885,595
 
Other accrued expenses
   
564,257
     
551,303
 
     
1,827,814
     
6,436,898
 

13. OTHER PAYABLES

Other payables as of March 31, 2011 and December 31, 2010 consisted of the following:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Payable for property, plant and equipment
   
23,789,025
     
23,473,721
 
Payable for purchase of biological assets
   
6,807,591
     
6,742,211
 
Payable for land use rights
   
1,012,544
     
1,001,325
 
Other tax payable
   
2,775,175
     
385,050
 
Deposits from distributors
   
2,572,285
     
2,057,685
 
Payable to local County Finance Bureau (i)
   
332,911
     
2,144,650
 
Advance received from Heilongjiang Yuanshengtai Farming Corporation for purchase of biological assets
   
-
     
891,436
 
Dividend payable to noncontrolling interests
   
-
     
208,226
 
Payable to an unrelated party, due on demand
   
442,600
     
442,600
 
Others (ii)
   
4,795,004
     
8,610,200
 
Total
   
42,527,135
     
45,957,104
 
 

(i)
The Group received funding from the local County Finance Department for construction of the production facilities in the region and working capital usage.  Although, no repayment terms were attached with the funds, the Group considers them to be unsecured, non-interest bearing loans from the County Finance Department that are repayable on demand.
 
 
14

 
 
(ii)
Others mainly includes deposits received from logistics companies and milk collection stations, prepayment made by employees on behalf of the Group, advertising cost and other miscellaneous payables.
 
14. LONG TERM BANK LOANS

Long term bank loans comprised of the following as of March 31, 2011 and December 31, 2010:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Loan payable to a bank in the PRC, bearing interest at 7.47%, unsecured, guaranteed by Feihe Dairy (i), and payable on maturity. The loan commenced in October 29, 2008 and matures on October 28, 2014
   
1,567,735
     
1,552,679
 
                 
Loan payable to a bank in the PRC, bearing interest at 7.47%, secured by biological assets, guaranteed by Feihe Dairy (i), and payable on maturity. The loan commenced on October 29, 2008 and matures on September 24, 2014
   
4,101,828
     
4,062,434
 
                 
Loan payable to a bank in the PRC, bearing interest at 7.47%, secured by biological assets, guaranteed by Feihe Dairy (i), and payable on maturity. The loan commenced on October 29, 2008 and matures on September 25, 2014
   
4,181,238
     
4,141,081
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.94%, secured by biological assets, guaranteed by Feihe Dairy (i) and payable on maturity. The loan commenced on June 29, 2009 and matures on October 28, 2014
   
7,212,559
     
7,143,289
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.94%, secured by biological assets, guaranteed by Feihe Dairy (i) and payable on maturity. The loan commenced on March 27, 2009 and matures on October 28, 2014
   
4,020,891
     
3,982,274
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.76%, secured by land use rights, plant and machinery. The loan commenced on December 24, 2009 and matures on December 23, 2014
   
5,085,409
     
5,036,569
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.76%, guaranteed by Langfang Feihe and payable on maturity. The loan commenced on December 24, 2009 and matures on December 23, 2014
   
8,658,616
     
8,575,458
 
                 
Loan payable to a bank in the PRC, bearing interest at 5.96%, secured by land use right of Gannan Feihe. The loan commenced on December 24, 2010 and matures on December 24, 2015
   
3,397,828
     
3,365,195
 
     
38,226,104
     
37,858,979
 
Less: current portion of long term bank loans
   
(10,985,643
)
   
(9,756,193
)
     
27,240,461
     
28,102,786
 
 

(i)
In connection with the purchase of property, plant and equipment of Kedong Farm, Feihe Dairy guaranteed the loans payable to a bank in the PRC for a period of one year, beginning on October 29, 2008 and ending on October 28, 2009. The maximum potential amount under the terms of the guarantee was $38,408,000 (or RMB 251,510,000).
 
 
15

 
 
15. CAPITAL LEASE OBLIGATION

In November 2009, the Group entered a six-year capital lease agreement for certain equipment under construction. The terms of the lease required an initial payment of RMB 5 million (or approximately $763,600) and require a RMB 1 million (or approximately $152,700) payment on January 30th of each year after successful completion of production quality tests. The installment and trial run of the equipment had been completed by December 31, 2010, and the equipment under the capital lease is depreciated over an estimated productive life of 14 years when placed into service after passing production quality tests.  As of March 31, 2011 and December 31, 2010, the Group had $1,531,047 and $1,516,343, respectively, of equipment subject to the capital lease obligation.

Minimum future lease payments under capital leases as of March 31, 2011, are as follows:

   
Future payments
 
   
US$
 
2011
   
152,711
 
2012
   
152,711
 
2013
   
152,711
 
2014
   
152,711
 
2015
   
152,713
 
Total minimum lease payments at March 31, 2011
   
763,557
 
Less amount representing interest
   
(99,322
)
Net present value of minimum lease payments
   
664,235
 
Current portion of capital lease obligation
   
(157,646
)
Non-current portion of capital lease obligation
   
506,589
 

The interest rate on the capital lease is 5.31%. There was $8,702 and $9,760 amortization of interest recorded for the three months ended March 31, 2011 and 2010, respectively. Accumulated amortization was $48,070 and $39,368 as of March 31, 2011 and December 31, 2010, respectively.
 
 
16

 
 
16. RELATED PARTY TRANSACTIONS

Due from/to related parties included in the condensed consolidated balance sheets as of March 31, 2011 and December 31, 2010 comprised the following:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Due from related parties:
           
  Due from directors of the Group
   
18,446
     
52,735
 
  Due from related companies
   
1,776,794
     
1,754,154
 
Total
   
1,795,240
     
1,806,889
 
 
 
17

 
 
   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Due to related parties:
           
  Due to directors of the Group
   
40,613
     
30,249
 
  Due to related companies
   
-
     
610
 
  Loan payable to a related party
   
48,868
     
48,398
 
Total
   
89,481
     
79,257
 

Due from/to Directors of the Group

As part of normal business operations, directors of the Group from time to time incur routine expenses on behalf of the Group, or receive general advances from the Group for settlement of Group expenses, such as travel, meals and other business expenses.  The amounts advanced are settled periodically throughout the period and amounts outstanding at period end are short term in nature and due on demand.  During the three month period ended March 31, 2011, advances to directors aggregated to $1,250 and repayments from directors aggregated to $35,539. During the three month period ended March 31, 2010, advances to directors aggregated to $5,801 and repayments from directors aggregated to $486. 
 
As of March 31, 2011 and December 31, 2010, the Group had the following balances due from its directors:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Leng You-Bin
   
-
     
34,466
 
Liu Hua
   
18,446
     
18,269
 
Total
   
18,446
     
52,735
 

As of March 31, 2011 and December 31, 2010, the Group had the following balances due to its directors:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
Leng You-Bin
   
30,542
     
30,249
 
Liu Sheng-Hui
   
10,071
     
-
 
Total
   
40,613
     
30,249
 
 
 
18

 
 
Due from/to related companies

For the three months ended March 31, 2011 and 2010, the Group made sales of goods to the following related companies:

   
For the three months ended
March 31,
 
   
2011
   
2010
 
   
US$
   
US$
 
             
Qianhuangdao Feihe Trading Company
   
-
     
1,406,868
 
Dalian Hewang Trading Company
   
56,273
     
96,129
 
Total
   
56,273
     
1,502,997
 

As of March 31, 2011 and December 31, 2010, the Group had the following balances due from its related companies:

   
March 31,
2011
   
December 31,
2010
 
   
US$
   
US$
 
             
Tangshan Feihe Trading Company
   
1,744,473
     
1,727,719
 
Qinhuangdao Feihe Trading Company
   
26,691
     
26,435
 
Dalian Hewang Trading Company
   
5,630
     
-
 
Total
   
1,776,794
     
1,754,154
 

Loan payable to a related party

The Group has an outstanding loan payable to a charitable organization set up by Leng You-Bin for underprivileged children in the Heilongjiang province of the PRC, of $48,868 and $48,398 as of March 31, 2011 and December 31, 2010, respectively.  The loan is unsecured and bears interest at 5.85% per annum and is payable on demand.
 
See Note 17 regarding the issuance of shares to Sequoia Capital China Growth Fund I, LP and certain of its affiliates and designees.

17. REDEEMABLE COMMON STOCK

On July 24, 2009, the Company entered into a Summary of Terms with Sequoia Capital China Growth Fund I, LP and certain of its affiliates and designees (collectively, “Sequoia”) in which Sequoia agreed to provide a 90-day bridge loan in the amount of $16 million. The bridge loan was funded on July 29, 2009. On August 26, 2009, pursuant to a subscription agreement (the “Subscription Agreement”) with Sequoia, the Company issued 2.1 million shares of its common stock for an aggregate purchase price of $63 million, including $47 million in cash and the conversion of the $16 million bridge loan. On August 26, 2009, the Company also entered into a registration rights agreement with Sequoia with respect to the shares. Pursuant to the registration rights agreement, the Company filed a registration statement covering the resale of the securities issued or issuable pursuant to the Subscription Agreement, which the SEC declared effective in October 2009. The registration rights agreement also granted demand and piggy-back registration rights to Sequoia.

The Company issued 525,000 shares of redeemable common stock to Sequoia in March 2010 pursuant to a performance adjustment clause in the Subscription Agreement because the Company failed to meet certain performance targets as of December 31, 2009. The 525,000 shares issued to Sequoia were valued at $11,382,000 and recorded as a performance share obligation as of December 31, 2009 and were classified as redeemable common stock during the first quarter of 2010.
 
 
19

 
 
Under the terms of the Subscription Agreement, the common stock issued to Sequoia was redeemable, at the option of the holder, if at any time after the third anniversary of the issuance date the average share closing prices of the Company’s common stock for the period of fifteen consecutive trading days were less than $39 per share, for an amount equal to $31.20, subject to certain adjustments. Due to the redeemable nature of the common stock issued to Sequoia, the Company classified the common stock as temporary equity upon issuance. Upon expiration of the redemption right, the common stock will be classified as shareholders’ equity.

The Company assessed the probability of redemption and accrued proper accretion on a quarterly basis. As of December 31, 2010, management determined that the probability of redemption was high and recognized $1,086,622 as accretion premium. The carrying value of redeemable common stock was $66,113,715 as of December 31, 2010.

On February 1, 2011, the Company entered into a redemption agreement (the “Redemption Agreement”) with Sequoia, pursuant to which the Company agreed to redeem and purchase from Sequoia an aggregate of 2,625,000 shares (the “Shares”) of the Company's common stock. Pursuant to the Redemption Agreement, the Company agreed to redeem the Shares in four equal installments on or around March 31, 2011, September 30, 2011, December 31, 2011 and March 31, 2012 (each, a “Closing Date”), for an aggregate payment on each Closing Date of $15,750,000, together with interest accruing at the rate of 1.5% per annum, compounded annually from August 27, 2009 until such Closing Date. As a result of the Redemption Agreement, the redeemable common stock became mandatorily redeemable and was reclassified into current liabilities at the settlement value of $65,079,979. The difference between the settlement amount and carrying amount of $1,033,736 was included in retained earnings. On April 27, 2011, the Company paid $16.1 million to Sequoia in redemption of 656,250 shares of common stock.

18. SHARE-BASED COMPENSATION

Share Options

The Company has two stock option plans:  the 2009 Stock Incentive Plan (the “2009 Plan”) and the 2003 Stock Incentive Plan (the “2003 Plan”).  The Company applies authoritative guidance issued by FASB regarding share-based payments in accounting for the 2003 Plan and the 2009 Plan, which requires that compensation for services that a corporation receives through share-based compensation plans should be measured by the quoted market price of the stock at the measurement date less the amount, if any, that the individual is required to pay.

(1) 2009 Stock Incentive Plan

On May 7, 2009, the Company’s Board of Directors approved the 2009 Plan, which was approved by the Company’s shareholders at the Company’s 2009 Annual Meeting of Shareholders. The 2009 Plan permits grants of incentive stock options, nonqualified stock options, restricted stock awards, performance stock awards and other equity-based compensation, to certain employees, directors, officers, consultants, agents, advisors and independent contractors of the Company and its subsidiaries. The total number of shares of the Company’s common stock initially authorized for issuance under the 2009 Plan was 2,000,000 plus any authorized shares that, as of May 7, 2009, were available for issuance under the 2003 Plan.

On May 7, 2009, the Compensation Committee of the Board of Directors granted an aggregate of 2,073,190 performance stock options to certain officers and employees of the Company under the 2009 Plan. The performance stock options each have an exercise price of $16.86, a contractual life of 6 years, and vest in two equal tranches on the fourth and fifth anniversaries of the date such options were granted, provided that the recipient has met the performance criteria established in accordance with the 2009 Plan, including performance targets that must be met in each of the Company’s 2009, 2010 and 2011 fiscal years, and the recipient continues to be an employee of, or service provider to, the Company or its subsidiaries at the time of the relevant vesting dates. If the performance criteria are not met, the options that would otherwise vest on the vesting dates are forfeited and cancelled.
 
 
20

 
 
The performance targets for the years ended December 31, 2009 and 2010 were not met for any option recipient.  In December 2009, the performance targets were amended in order to limit the amount of options that would otherwise be forfeited and cancelled by all recipients of the performance stock options. The incremental cost or benefit resulting from the modification is measured as the excess of the fair value of the modified award over the fair value of the original award immediately before its terms are modified and the effect on the number of instruments expected to vest. As a result of this modification, $610,054 and $1,511,623 in incremental compensation cost was recognized during the years ended December 31, 2010 and 2009. This modification affected 421 employees.
 
The fair value of the option awards were estimated on the date of grant using the Black-Scholes option valuation model to be $22,106,218, of which $335,002 and $647,839 was recorded as compensation expense in general and administrative expenses in the three months ended March 31, 2011 and 2010, respectively.  The valuation was based on the assumptions noted in the following table.
 
Expected volatility
   
74.94
%
Expected dividends
   
0
%
Expected term (in years) 
   
 5.25
 
Risk-free rate
   
2.27
%

On October 15, 2009, an option to purchase 50,000 shares was granted to an employee that vested on the 12-month anniversary of the date of grant, conditioned upon continued employment on such date, and had an exercise price of $16 and a contractual life of 4 years.  The fair value of the option award was estimated on the date of grant using the Black-Scholes option valuation model to be $1,103,400, of which $nil and $272,786 was recorded as compensation cost in the three months ended March 31, 2011 and 2010, respectively. The valuation was based on the assumptions noted in the following table.
 
Expected volatility
   
93
%
Expected dividends
   
0
%
Expected term (in years)
 
2.5
 
Risk-free rate
   
1.24
%

On October 23, 2009, the Compensation Committee of the Board of Directors granted an aggregate of 30,000 new performance stock options to an employee of the Company under the 2009 Plan. The performance stock options have an exercise price of $27.69 and a contractual life of 6 years, and vest in two equal tranches on the fourth and fifth anniversaries of the date such options were granted, provided that the recipient has met the performance criteria established in accordance with the 2009 Plan, including performance targets that must be met in each of the Company’s 2009, 2010 and 2011 fiscal years, and the recipient continues to be an employee of, or service provider to, the Company or its subsidiaries at the time of the relevant vesting dates. If the performance criteria are not met, the options that would otherwise vest on the vesting dates are forfeited and cancelled.

The fair value of the option awards were estimated on the date of grant using the Black-Scholes option valuation model to be $565,900, of which $30,822 and $32,329 was recorded as compensation expense in general and administrative expenses during the three months ended March 31, 2011 and 2010, respectively.  The valuation was based on the assumptions noted in the following table.
 
Expected volatility
   
83
%
Expected dividends
   
0
%
Expected term (in years) 
   
 5.25
 
Risk-free rate
   
2.59
%
 
 
21

 
 
On August 27, 2010, options to purchase 84,000 shares were granted to directors of the Company for their services provided for the period from August 1, 2010 through July 31, 2011.  The options vested in four equal amounts on each three-month anniversary of the grant date until all such shares are fully vested. The options have an exercise price of $7.25 and a contract life of 2 years. The fair value of the option award is estimated on the date of grant using the Black-Scholes option valuation model to be $164,500, of which $36,330 and $nil was recorded as compensation cost in the three months ended March 31, 2011 and 2010, respectively.  The valuation was based on the assumptions noted in the following table.
 
Expected volatility
   
54
%
Expected dividends
   
0
%
Expected term (in years) 
   
 0.81
 
Risk-free rate
   
0.22
%
  
(2) 2003 Stock Incentive Plan

Effective May 7, 2003, the Company adopted and approved its 2003 Stock Incentive Plan (the “2003 Plan”), which reserved 3,000,000 shares of common stock for issuance under the 2003 Plan. The 2003 Plan allows the Company to issue awards of incentive non-qualified stock options, stock appreciation rights, and stock bonuses to directors, officers, employees and consultants of the Company which may be subject to restrictions.

No stock appreciation rights have been issued under the 2003 Plan.

On October 15, 2008, an option to purchase 80,000 shares was granted to an employee that vested on the 12-month anniversary of the date of grant, conditioned upon continued employment on such date, and had an exercise price of $12.00 and a contractual life of 4 years. The fair value of the option award were estimated on the date of grant using the Black-Scholes option valuation model to be $562,758, of which $422,069 and $140,689 were recorded as compensation cost in the general and administrative expenses during the years ended December 31, 2009 and 2008. The valuation was based on the assumptions noted in the following table.

Expected volatility
   
90.7
%
Expected dividends
   
0
%
Expected term (in years) 
   
2.5
 
Risk-free rate
   
2.7
%

A summary of option activity under the 2009 Plan and 2003 Plan as of March 31, 2011 and movement during the three months then ended are as follow:

   
Options
   
Weighted
average
grant date
fair value
   
Weighted
average
exercise price
   
Aggregate
intrinsic
value
   
Weighted
average
remaining
contractual
term
 
         
US$
   
US$
   
US$
       
Outstanding as of January 1, 2011
   
856,245
     
10.45
     
15.84
     
71,190
     
3.97
 
Granted
   
-
     
-
     
-
     
-
     
-
 
Exercised
   
-
     
-
     
-
     
-
     
-
 
Forfeited or expired
   
(122,000
   
13.19
     
13.64
     
-
     
1.92
 
Outstanding as of March 31, 2011
   
734,245
     
10.00
     
16.20
     
114,240
     
3.79
 
Exercisable as of March 31, 2011
   
42,000
     
1.96
     
7.25
     
-
     
1.40
 
 
 
22

 
 
A summary of the status of the Company’s non-vested options as of March 31, 2011 and movements during the three months then ended are as follow:

   
Options
   
Weighted average
grant date fair
value
 
         
US$
 
Non-vested as of January 1, 2011
   
713,245
     
10.24
 
Granted
   
-
     
-
 
Vested
   
(21,000
   
1.96
 
Forfeited or expired
   
-
     
-
 
Non-vested as of March 31, 2011
   
692,245
     
10.49
 
 
As of March 31, 2011, there was $3,892,778 of unrecognized compensation cost related to non-vested share-based compensation granted under the 2009 Plan and the 2003 Plan.  The cost is expected to be recognized over various periods ranging from 2 months to 45 months.

Warrants

As of March 31, 2011, the Company had 237,937 warrants outstanding with a weighted average remaining contractual life of 1.5 years and a weighted average exercise price of $14.50. The warrants will expire on October 4, 2012.

During the three months ended March 31, 2011 and 2010, no warrants were exercised.

   
Warrants
   
Average exercise
Price
 
         
US$
 
Outstanding warrants as of January 1, 2011
   
237,937
     
14.50
 
Warrants granted
   
-
     
-
 
Exercised
   
-
     
-
 
Expired
   
-
     
-
 
Outstanding warrants as of March 31, 2011
   
237,937
     
14.50
 

19. COMMITMENTS AND CONTINGENCIES

Capital commitments for purchase of property, plant and equipment and biological assets as of March 31, 2011 were $3,075,026. The Group has certain purchase commitments of $7,096,176 over six years relating to packaging materials in connection with the capital lease obligation disclosed in Note 15.

20. SEGMENTS

The segment information for the operating segments for the three months ended March 31, 2011 was as follows:

   
Dairy products
   
Dairy farms
   
Corporate
   
Total
 
   
US$
   
US$
   
US$
   
US$
 
Revenues from external customers
   
67,678,513
     
8,770,909
     
-
     
76,449,422
 
Intersegment revenues
   
5,490
     
3,945,268
     
-
     
3,950,758
 
Segment income tax
   
1,337,800
     
-
     
3,883
     
1,341,683
 
Segment income (loss) before income tax
   
5,965,709
     
565,444
     
(449,927
)
   
6,081,226
 
Segment assets
   
507,687,929
     
175,542,522
     
192,580,550
     
875,811,001
 
 
 
23

 
 
The segment information for the operating segments for the three months ended March 31, 2010 was as follows:

   
Dairy products
   
Dairy farms
   
Corporate
   
Total
 
   
US$
   
US$
   
US$
   
US$
 
Revenues from external customers
   
81,435,903
     
-
     
-
     
81,435,903
 
Intersegment revenues
   
-
     
3,814,064
     
-
     
3,814,064
 
Segment income tax
   
1,555,817
     
-
     
30,000
     
1,585,817
 
Segment income (loss) before income tax
   
10,818,558
     
(1,937,448
)
   
(1,823,390
)
   
7,057,720
 
Segment assets
   
502,550,980
     
154,310,071
     
191,452,079
     
848,313,130
 

A reconciliation of operating segment revenue and assets to the Group’s totals was as follows:

 
Three months ended
March 31,
 
 
2011
   
2010
 
Revenues
US$
   
US$
 
Total revenues for operating segments
   
80,400,180
     
85,249,967
 
Elimination of intersegment revenues
   
(3,950,758
)
   
(3,814,064
)
Total consolidated revenues
   
76,449,422
     
81,435,903
 

   
March 31,
2011
   
December 31,
2010
 
Assets
 
US$
       
Total assets for operating segments
   
875,811,001
     
874,738,492
 
Elimination of investment
   
(120,970,781
)
   
(120,808,394
)
Elimination of intercompany receivables
   
(291,565,195
)
   
(289,620,816
)
Total consolidated assets
   
463,275,025
     
464,309,282
 
 
21. SUBSEQUENT EVENTS
 
On April 27, 2011, the Company paid $16.1 million, including $15.8 million together with interest accruing thereon at the rate of 1.5% per annum, compounded annually from August 27, 2009 until April 27, 2011, to Sequoia in redemption of 656,250 shares of redeemable common stock pursuant to the Redemption Agreement with Sequoia (see Note 17).

 
24

 

FORWARD-LOOKING STATEMENTS

The statements included in this report that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and Section 27A of the Securities Act of 1933, as amended. These statements include, but are not limited to, statements about our plans, objectives, expectations, strategies, intentions or other characterizations of future events or circumstances and are generally identified by the words “may,” “expects,” “anticipates,” “intends,” “plans,” “targets,” “believes,” “seeks,” “estimates,” “could,” “would,” and similar expressions. Because these forward-looking statements are subject to a number of risks and uncertainties, our actual results could differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the heading “Risk Factors” in our Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2010, as amended and in other documents we file from time to time with the U.S. Securities and Exchange Commission, or the SEC. All forward-looking statements included in this report are based on information available to us on the date hereof. Our business and the associated risks may have changed since the date this report was originally filed with the SEC. We assume no obligation to update any such forward-looking statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and related notes appearing elsewhere in this Quarterly Report.  In addition to historical financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Quarterly Report.

Overview

We are a leading producer and distributor of milk powder, soybean milk powder, and related dairy products in the People’s Republic of China, or the PRC.  Using proprietary processing techniques, we make products that are specially formulated for particular ages, dietary needs and health concerns.  We have over 200 company-owned milk collection stations, seven production and distribution facilities with an aggregate milk powder production capacity of approximately 1,950 tons per day, and an extensive distribution network that reaches over 80,000 retail outlets throughout China.

Factors Affecting our Results of Operations

Our operating results are primarily affected by the following factors:
 
 
·
Dairy Industry Growth.  We believe the market for dairy products in China for the long term will be growing rapidly, driven by China’s economic growth, increased penetration of infant formula, and a growing female working population.  Despite the damage to the industry as a result of the melamine crisis in 2008, which did not involve any of our products, we expect these factors to continue to drive industry growth. We believe that the rapid economic growth of our primary markets has become an increasingly important driver of growth.
 
 
·
Production Capacity. We believe much of the dairy market in China is still underserved, particularly with respect to infant formula.  In addition, since the melamine crisis in 2008, we have expanded the production capabilities at our Gannan facility and added the production facility in Longjiang to our current production capabilities. Accordingly, we believe that the ability to increase production of high quality dairy products will allow well-positioned companies to significantly increase revenues and market share.
 
 
25

 
               
 
·
Perceptions of Product Quality and Safety. We believe that rising consumer wealth in China has contributed to a greater demand for higher-priced products with perceived quality advantages.  We believe many consumers in China tend to regard higher prices as indicative of higher quality and higher nutritional value, particularly in the areas of infant formula and nutritional products.  Accordingly, we believe our reputation for quality and safety allows us to command higher average selling prices and generate higher gross margins than competitors who do not possess the same reputation.  Conversely, any decrease in consumer perceptions of quality and safety could adversely impact us.
 
 
·
Seasonality.  The dairy industry remains seasonal, with higher production in the summer season and greater demand in winter months. This seasonality is offset by production of powder products with longer shelf lives.
               
 
·
Raw Material Supply and Prices.  The per unit costs of producing our infant formula are subject to the supply and price volatility of raw milk and other raw materials, which are affected by the PRC and global markets. For example, in 2008 our raw milk prices increased by approximately 45%, in 2009 decreased by approximately 20% and in 2010 increased by approximately 24%, and we expect they will continue to be affected by factors such as geographic location, rising feed prices, general economic conditions such as inflation and fuel prices, and fluctuations in production, rising production costs and competition, as well as increased competition abroad and currency fluctuations.  Our milk cost associated with fresh milk sourced from our company-owned dairy farms is also impacted by governmental agricultural and environmental policies, subsidies, technical assistance and other agricultural regulations and policies, as well as the productivity of our dairy cows, which can be influenced natural and environmental factors.
  
 
·
Expenses Associated with Expansion and Competition.  In implementing our plan to expand our business, we face corresponding increases in expenses, especially for selling and marketing expenses, in order to attract and retain qualified talent, monitor our sales by region and address potential cross-territory selling activities by distributors, implement strategic advertising campaigns, and finance our expansion.  
 
Results of Operations

The following table sets forth certain information regarding our results of operations.

   
Three Months Ended
March 31,
 
   
2011
   
2010
 
   
($ in thousands)
 
Sales
   
76,449
     
81,436
 
Cost of goods sold
   
(48,578
)
   
(42,998
Gross profit
   
27,871
     
38,438
 
Operating expenses:
               
Sales and marketing expenses
   
(16,170
)
   
(28,282
General and administrative expenses
   
(6,229
)
   
(5,494
Loss on disposal of biological assets
   
(1,602
)
   
(2,785
)
Other operating income, net
   
2,094
     
209
 
                 
Operating income
   
5,964
     
2,086
 
Other income, net
   
117
     
4,972
 
Income tax expense
   
(1,342
)
   
(1,586
Net income attributable to common shareholders of Feihe International, Inc.
   
4,697
     
5,534
 

 
26

 
 
Comparison of Three Month Periods Ended March 31, 2011 and 2010

Sales
 
Our sales consist primarily of revenues generated from sales of milk powder, raw milk powder, raw milk, soybean powder, rice cereal, and walnut products.  Sales decreased by approximately $5.0 million, or 6.1%, from approximately $81.4 million for the three month period ended March 31, 2010 to approximately $76.4 million for the three month period ended March 31, 2011.  This decrease was primarily attributable to decrease of sales of milk powder of approximately $16.9 million, offset in part by an increase in sales of raw milk powder of approximately $3.7 million and an increase in sales of raw milk of approximately $8.8 million. Our sales in the three month period ended March 31, 2011 increased sequentially from approximately $62.3 million, or 22.6%, in the fourth quarter of 2010, primarily reflecting our efforts to increase sales at existing retail sales points, as well as our continued commitment improving the effectiveness of all functions of our operations. With new competitors entering into our industry and old competitors aggressively attempting to reclaim market share following the melamine crisis, we expect to face increased competition.
 
The following table sets forth information regarding the sales of our principal products during the three month periods ended March 31, 2011 and 2010:

   
Three months ended
March 31,
2011
   
Three months ended
March 31,
2010
   
Three months ended
March 31,
2011 over 2010
 
Product
name
 
Quantity
(Kg’000)
   
Amount
($’000)
   
% of
Sales
   
Quantity
(Kg’000)
   
Amount
($’000)
   
% of
Sales
   
Quantity
(Kg’000)
   
Amount
($’000)
   
% of
Sales
 
                                                       
Milk powder
   
5,007
     
47,901
     
62.7
     
8,544
     
64,806
     
79.6
     
(3,537
)
   
(16,905
)
   
(26.1
Raw milk powder
   
3,968
     
16,129
     
21.1
     
3,525
     
12,423
     
15.2
     
443
     
3,706
     
29.8
 
Raw milk
   
13,018
     
8,771
     
11.5
     
-
     
-
     
-
     
13,018
     
8,771
     
100.0
 
Soybean powder
   
1,217
     
1,940
     
2.5
     
1,532
     
1,927
     
2.4
     
(315
)
   
13
     
0.7
 
Rice cereal
   
173
     
1,152
     
1.5
     
257
     
1,623
     
2.0
     
(84
)
   
(471
)
   
(29.0
Walnut products
   
50
     
307
     
0.4
     
88
     
451
     
0.6
     
(38
)
   
(144
)
   
(31.9
Other
   
70
     
249
     
0.3
     
20
     
206
     
0.2
     
50
     
43
     
20.9
 
Total
   
23,503
     
76,449
     
100
     
13,966
     
81,436
     
100
     
9,537
     
(4,987
)
   
(6.1
)

In the three month period ended March 31, 2011, we had a decrease in the average sales price per kilogram of our products, as demonstrated in the table below:

   
Three Months Ended
March 31,
 
   
2011
   
2010
 
Sales revenues (in thousands)
 
$
76,449
   
$
81,436
 
Total sales volume (kilograms in thousands)
   
23,503
     
13,966
 
Average selling prices/kilogram
 
$
3.25
   
$
5.83
 

The decrease in average sales price per kilogram, as reflected in the table, was primarily attributable to a shift in product mix resulting from a decrease in sales of milk powder, a higher margin product. The following table reflects the average sales price per kilogram by product for the three month periods ended March 31, 2011 and 2010, and the percentage change in the sales price per kilogram.

   
Average Price Per Kilogram
       
   
Three Months ended March 31,
   
Percentage
 
Product name
 
2011
   
2010
   
Change
 
Milk powder
 
$
9.57
   
$
7.59
     
26.1
 
Raw milk powder
   
4.07
     
3.52
     
15.3
 
Raw milk
   
0.67
     
-
     
100.0
 
Soybean powder
   
1.59
     
1.26
     
26.7
 
Rice cereal
   
6.65
     
6.32
     
5.3
 
Walnut products
   
6.08
     
5.13
     
18.6
 
Other
   
3.60
     
10.30
     
(65.1
Average selling price s/kilogram
 
$
3.25
   
$
5.83
     
(44.2
 
 
27

 
 
The average selling price per kilogram of milk powder increased by 26.1% from $7.59 in the three month period ended March 31, 2010 to $9.57 in the three month period ended March 31, 2011.  This increase was primarily attributable to fewer promotional activities, including a decrease in sales discounts provided to distributors and decreased display fees, which were deducted from gross sales. The average selling price per kilogram for raw milk powder increased by 15.3%, from $3.52 in the three month period ended March 31, 2010 to $4.07 in the three month period ended March 31, 2011.  
 
Cost of Goods Sold
 
Our cost of goods sold consist primarily of direct and indirect manufacturing costs, including production overhead costs and shipping and handling costs for the products sold.  Cost of goods sold increased approximately $5.6 million, or 13.0%, from approximately $43.0 million for the three month period ended March 31, 2010 to approximately $48.6 million for the three month period ended March 31, 2011.  This increase was primarily attributable to general increases in raw milk and costs of added nutrients.

Gross Profit Margin
 
Our gross profit margin decreased from 47.2% for the three month period ended March 31, 2010 to 36.5% for the three month period ended March 31, 2011. This decrease was primarily attributable to a decrease in our sales quantities of milk powder and an increase in sales quantities of raw milk powder, which has a lower gross profit margin than milk powder, as well as increases in the price of raw milk.

Operating Expenses
 
Our total operating expenses consist primarily of sales and marketing expenses, general and administrative expenses and loss on disposal of biological assets.  Our total operating expenses decreased by approximately $12.6 million, or 34.4%, from approximately $36.6 million for the three month period ended March 31, 2010 to approximately $24.0 million for the three month period ended March 31, 2011. This decrease was primarily attributable to a decrease of approximately $12.1 million, or 42.8%, in sales and marketing expenses from approximately $28.3 million for the three month period ended March 31, 2010 to approximately $16.2 million for the three month period ended March 31, 2011 and a decrease of approximately $1.2 million, or 42.9%, in loss on disposal of biological assets from approximately $2.8 million for the three month period ended March 31, 2010 to approximately $1.6 million for the three month period ended March 31, 2011. The decreased loss on disposal of biological assets reflected a decrease in sales of under-producing cows at our company-owned dairy farms. The decreased sales and marketing expenses primarily related to a decrease in advertising and promotional fees, and also reflected our efforts to improve the effectiveness of our selling expenses for the three month period ended March 31, 2011. This decrease was offset in part by an increase of approximately $0.7 million, or 13.4%, in general and administrative expenses from approximately $5.5 million for the three month period ended March 31, 2010 to approximately $6.2 million for the three month period ended March 31, 2011.

Other operating income, net
 
Our other operating income, net consists primarily of contractual payments received from our distributors who engaged in cross-territory selling activities prohibited by their contracts with us.  Our other operating income, net increased approximately $1.9 million, or 902%, from approximately $209,000 for the three month period ended March 31, 2010 to approximately $2.1 million for the three month period ended March 31, 2011.

Operating Income
 
As a result of the foregoing, we had operating income of approximately $6.0 million for the three month period ended March 31, 2011, representing an increase of approximately $3.9 million, or 186.0%, from income of approximately $2.1 million in the three month period ended March 31, 2010.

 
28

 
 
Other Income (Expenses)
 
Our other income (expenses) consists primarily of interest income, interest and finance costs and government subsidies.  Other income (expenses) decreased approximately $4.9 million, or 97.6%, from approximately $5.0 million for the three month period ended March 31, 2010 to approximately $0.1 million for the three month period ended March 31, 2011.  The decrease was primarily attributable to a decrease of government subsidy of approximately $4.2 million, or 73.3%, from approximately $5.7 million for the three month period ended March 31, 2010 to approximately $1.5 million for the three month period ended March 31, 2011, and an increase in interest and finance costs of approximately $0.6 million, or 70.3%, from approximately $0.8 million for the three month period ended March 31, 2010 to approximately $1.4 million for the three month period ended March 31, 2011.
 
Income Tax Expense
 
We are subject to U.S. federal and state income taxes, and our subsidiaries incorporated in the PRC are subject to enterprise income taxes in the PRC.  We recorded an income tax expense of approximately $1.3 million and $1.6 million for the three months ended March 31, 2011 and 2010, respectively.  The decrease in income tax expense was primarily due to the decrease in profits of Gannan Feihe, which is one of our major operations.
 
As of March 31, 2011, unrecognized tax benefits were approximately $5.0 million.  The total amount of unrecognized tax benefits that, if recognized, would favorably affect the effective tax rate was $3.2 million as of March 31, 2011. As of March 31, 2010, unrecognized tax benefits were approximately $5.7 million.  The total amount of unrecognized tax benefits that, if recognized, would favorably affect the effective tax rate was $3.2 million as of March 31, 2010.
 
We cumulatively accrued approximately $1.8 million and $1.2 million for estimated interest and penalties related to unrecognized tax benefits as of March 31, 2011 and as of March 31, 2010, respectively.  For the three months ended March 31, 2011 and March 31, 2010, we recorded $155,000 and $152,000 of estimated interest and penalties, respectively.
 
Liquidity and Capital Resources

In general, our primary uses of cash are providing for working capital purposes, which principally represent the purchase of inventory, servicing debt and financing construction related to our expansion plans. Our largest source of operating cash flows is cash collections from our customers. We have been able to meet our cash needs principally by using cash on hand, cash flows from operations, bank loans and borrowings under our line of credit.

The accompanying unaudited condensed consolidated financial statements have been prepared assuming we will continue as a “going concern.” We had a deficiency of net current assets of approximately $115.7 million as of March 31, 2011. We have significant cash commitments in the upcoming year, including maturity of short-term loans of approximately $69.5 million and redemption of redeemable common stock of approximately $63 million plus interest. However, we believe we will be able to refinance much of our short-term bank loans when they become due and that our cash generated from operations, along with existing cash and ability to draw down on unutilized credit lines, will be sufficient to fund our expected cash flow requirements for at least next 12 months, including the cash payment for the redemption of our redeemable common stock and planned capital expenditures. In the first quarter of 2011, we refinanced a short-term bank loan upon its maturity.

Cash Flows
 
As of March 31, 2011, we had retained earnings of approximately $66.5 million, cash and cash equivalents of approximately $19.1 million, total current assets of approximately $138.1 million and a working capital deficit of approximately $115.7 million.
 
 
29

 
 
Our summary cash flow information is as follows:

   
Three Months Ended
March 31,
 
Net cash provided by (used in):
 
2011
   
2010
 
   
($ in thousands)
 
Operating activities
   
3,706
     
22,940
 
Investing activities
   
(2,318
)
   
(18,355
Financing activities
   
5
     
(7,065
)

Net Cash Provided by Operating Activities
 
Net cash provided by operating activities decreased approximately $19.2 million, from approximately $22.9 million for the three month period ended March 31, 2010 to approximately $3.7 million for the three month period ended March 31, 2011. This decrease was primarily attributable to the following changes in working capital items:

 
·
decrease in trade receivables of approximately $6.6 million reflecting our strengthening on collection of receivables from the distributors;
 
 
·
decrease in inventory of approximately $9.6 million reflecting our efforts to increase sales in raw milk powder and speed up the collection of cash;
 
 
·
increase in advances to suppliers of approximately $4.7 million as a result of increased production combined with the rising costs of raw material;
 
 
·
increase in other receivable of approximately $5.9 million was primarily due to the increase of the amount we have paid in advance for the purchase of cattle and equipments for another company;
 
 
·
decrease in accrued expenses of approximately $11.4 million, as a result of effective control on selling expenses and less expenses were needed to be accrued with reduced expenditures; and
 
 
·
increase in advances from customers of approximately $3.9 million for raw milk powder primarily attributable to increased sales of raw milk powder despite an overall decrease in sales.

Net Cash Used in Investing Activities
 
Net cash used in investing activities decreased approximately $16.1 million, from approximately $18.4 million in the three month period ended March 31, 2010 to approximately $2.3 million for the three month period ended March 31, 2011.  This decrease was primarily attributable to a decrease of approximately $2.5 million in purchase of property, plant and equipment, a decrease of approximately $12.2 million in restricted cash and a decrease of approximately $1.5 million in purchase of short term investment. Net cash used in investing activities primarily relates to our bank loans and expenditures associated with our construction of new facilities.

Net Cash Provided by (Used in) Financing Activities
 
Net cash provided by financing activities increased approximately $7.1 million, from net cash used in financing activities of approximately $7.1 million for the three month period ended March 31, 2010 to net cash provided by financing activities of approximately $5,000 for the three month period ended March 31, 2011.  This increase was primarily attributable to a decrease of approximately $8.3 million in repayment of short term bank loans. This decrease was offset in part by a decrease of approximately $1.0 million in proceeds from short term bank loans.
 
Outstanding Indebtedness

Redemption Obligation
 
In August 2009, pursuant to a subscription agreement, we issued 2,100,000 shares of our common stock to Sequoia, for an aggregate purchase price of $63.0 million. Because we did not meet certain earnings per share targets for 2009, we issued 525,000 additional shares to Sequoia pursuant to the subscription agreement. In February 2011, we entered into a redemption agreement with Sequoia to redeem and repurchase 2,625,000 shares issued pursuant to the subscription agreement in four equal installments on or around March 31, 2011, September 30, 2011, December 31, 2011 and March 31, 2012, for an aggregate payment on each such date of $15,750,000, together with interest accruing at the rate of 1.5% per annum, compounded annually from August 27, 2009 until such date.
 
 
30

 
 
On April 27, 2011, we paid Sequoia $16.1 million to redeem 656,250 shares of common stock.

Short and Long Term Bank Loans Payable
 
As of March 31, 2011, we had short term bank loans of approximately $69.5 million and long term bank loans of approximately $38.2 million from PRC banks. Our bank loans do not contain financial covenants. During the three month period ended March 31, 2011, the largest aggregate amount of short term bank loans was approximately $69.5 million. The maturity dates of the short term bank loans outstanding from PRC banks as of March 31, 2011 ranged from July 25, 2011 to January 25, 2012. All short term bank loans that have become due have been repaid. During the three month period ended March 31, 2011, the largest aggregate amount of long term bank loans was approximately $38.2 million. The maturity dates of the long term bank loans outstanding from PRC banks as of March 31, 2011 ranged from September 24, 2014 to December 24, 2015. The weighted average interest rate on short term bank loans and long term bank loans from PRC banks outstanding as of March 31, 2011 was 5.5% and 6.3%, respectively. The loans were secured by pledges of certain property, plant and equipment held by our subsidiaries or by guarantees of certain of our subsidiaries. Our ability to incur additional secured indebtedness depends in part on the value of our assets, which depends, in turn, on the strength of our cash flows, results of operations, economic and market conditions and other factors.

Line of Credit
 
We also have a one year, unsecured line of credit with a bank of approximately $103 million (RMB 677 million) scheduled to expire in the last fiscal quarter of 2011. The line of credit entitles us to draw demand loans for general corporate purposes. If we were to draw on the line of credit, interest would be a base rate established by the People’s Bank of China on the unpaid principal amount. As of March 31, 2011, there were borrowings of approximately $31 million under the line of credit. The net availability of the line of credit was approximately $72 million as of March 31, 2011.

Equipment Financing
 
In November 2009, we entered into a six-year capital lease agreement for certain equipment under construction. The terms of the lease required an initial payment of approximately $763,600 and a payment of approximately $152,700 on January 30th of each year after successful completion of production quality tests. The equipment has been successfully installed and put into production as of December 31, 2010, and was depreciated over an estimated productive life of 14 years. As of March 31, 2011 and December 31, 2010, we had approximately $1.5 million, respectively, of equipment subject to the capital lease.

Off-Balance Sheet Arrangements

We have not entered into any transactions, agreements or other contractual arrangements to which an entity unconsolidated with us is a party and under which we have (i) any obligation under a guarantee, (ii) any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity, (iii) any obligation under derivative instruments that are indexed to our shares and classified as shareholders’ equity in our consolidated balance sheets, or (iv) any obligation arising out of a variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.
 
 
31

 
 
Critical Accounting Policies

The consolidated financial statements include the financial statements of us and our subsidiaries. All transactions and balances among us and our subsidiaries have been eliminated upon consolidation. Certain amounts included in or affecting our consolidated financial statements and related disclosures must be estimated, requiring us to make certain assumptions with respect to values or conditions that cannot be known with certainty at the time the financial statements are prepared. These estimates and assumptions affect the amounts we report for assets and liabilities, our disclosure of contingent assets and liabilities at the date of our financial statements, and the reported amounts of revenues and expenses during the reported periods. We routinely evaluate these estimates, utilizing historical experience, consulting with experts and utilizing other methods we consider reasonable in the particular circumstances. Nevertheless, actual results may differ significantly from our estimates. Any effects on our business, financial position or results of operations resulting from revisions to these estimates are recorded in the period in which the facts that give rise to the revision become known.

Estimates of allowances for bad debts – We periodically review our trade and other receivables to determine if all are collectible or whether an allowance is required for possible uncollectible balances. We perform this review quarterly, and in determining the allowances, a number of factors are considered, including the length of time the receivable is past due, past loss history, the counter party’s current ability to pay and the general condition of the economy and industry. As a result of this review and collection of older receivables, we have increased our estimated allowance for bad debts by $503,431 for the three months ended March 31, 2011 and reduced it by $261,959 for the three months ended March 31, 2010. Although our write-offs of bad debts have been minimal in recent years and we had no write-offs in the three months ended March 31, 2011, events and circumstances could occur that would require that we increase our allowance in the future.

Estimate of the useful lives of property, plant and equipment and biological assets – We estimate the useful lives and residual values of our property, plant and equipment and biological assets. We also review property, plant and equipment and biological assets for possible impairment whenever events and circumstances indicate that the carrying value of those assets may not be recovered from the estimated future cash flows expected to result from their use and eventual disposition. We recognized no impairments in the periods ended March 31, 2011 and 2010. For our cows included in the biological assets, we regularly monitor their production level and intend to dispose of under producing cows. We recognized approximately $1.6 million and $2.8 million of loss on such disposal for the three months ended March 31, 2011 and 2010, respectively.

Inventory – We value inventories at the lower of cost or market value. We determine the cost of inventories using the weighted average cost method and include any related production overhead costs incurred in bringing the inventories to their present location and condition. We determine whether we have any excessive, slow moving, obsolete or impaired inventory. We perform this review quarterly, which requires management to estimate the future demand of our products and market conditions. We make provisions on the value of inventories at period end equal to the difference between the cost and the estimated market value. If actual market conditions change, additional provisions may be required.

Goodwill – We test goodwill annually for impairment or more frequently if events or changes in circumstances indicate that it might be impaired. We currently have ten reporting units and only one reporting unit carries assigned goodwill: Gannan Feihe. We perform annual impairment test on December 31 on this reporting unit. We recognize a goodwill impairment loss in our statements of operations when the carrying amount of goodwill exceeds its implied fair value based on their undiscounted cash flows. These analyses require management to make assumptions and to apply judgment, including forecasting future sales, expenses, and discount rates, which can be affected by economic conditions and other factors that can be difficult to predict. We perform the impairment test at the end of the fourth quarter each year.

Revenue recognition – Revenue from the sale of goods is recognized on the transfer of risks and rewards of ownership, which generally coincides with the time when the goods are shipped to customers and the title has passed. Revenue is shown net of sales returns, which amounted to less than 0.8% of total sales for the three months ended March 31, 2011 and 2010, respectively, and net of sales discounts, which is determined based on our distributors’ sales volumes.
 
 
32

 
 
Share-based compensation – Share-based compensation to employees is measured by reference to the fair value of the equity instrument as at the date of grant using the Black-Scholes model, which requires assumptions for dividend yield, expected volatility and expected life of stock options. The expected life of stock options is estimated by observing general option holder behavior. The assumption of the expected volatility has been set by reference to the implied volatility of our shares in the open market and historical patterns of volatility. Performance and service vesting conditions attached to the options are included in assumptions about the number of shares that the option holder will ultimately receive. On a regular basis we review the assumptions made and revise the estimates of the number of options expected to be settled, where necessary. Significant factors affecting the fair value of option awards include the estimated future volatility of our stock price and the estimated expected term until the option award is exercised or cancelled.

The fair value of awards is amortized over the requisite service period, except for 2,073,190 options granted in May 2009 that vest upon performance conditions. For such performance based awards, we assess the probability of meeting such conditions in order to determine the compensation cost to be recognized. For three months ended March 31, 2011 and 2010, we determined that it was improbable for the performance targets to be met for the performance awards. Total compensation expense recognized in general and administrative expenses for the three months ended March 31, 2011 and 2010, were approximately $0.4 million and $1.0 million, respectively.

Redeemable common stock – On February 1, 2011, we entered into a redemption agreement committing us to redeem the common stock at a total price of $63 million plus 1.5% annual compounded interest, beginning from August 27, 2009. We agreed to consummate the redemption in four closings from March 31, 2011 through March 31, 2012.  As a result, the redeemable common stock was reclassified into current liabilities with the difference between the carrying value and settlement amount included in retained earnings.

Taxation – Current income taxes are provided for in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized for temporary differences between the tax bases of assets and liabilities and their reported amounts in the financial statements. Net operating loss carry forwards and credits are applied using enacted statutory tax rates applicable to future years. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The components of the deferred tax assets and liabilities are individually classified as current and non-current based on their characteristics.

We adopted ASC 740-10, “Income Taxes” (previously FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an Interpretation of FASB Statement No. 109,” or FIN 48) effective April 1, 2007. In accordance with ASC 740-10, we recognize a tax benefit associated with an uncertain tax position when, in our judgment, it is more likely than not that the position will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, we initially and subsequently measure the tax benefit as the largest amount that we judge to have a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority. Our liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the progress of tax audits, case law developments and new or emerging legislation. Such adjustments are recognized entirely in the period in which they are identified. Our effective tax rate includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. We classify interest and penalties recognized on the liability for unrecognized tax benefits as income tax expense.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

We invest in fixed and variable income investments classified as cash and cash equivalents and short-term investments.  Our cash and cash equivalents are placed primarily in demand deposits, with maturities of three months or less and short-term investments are mutual funds.  Our borrowings bear fixed interest rates.  As of March 31, 2011, we had short term loans of approximately $69.5 million and long term loans of approximately $38.2 million from PRC banks, the weighted average interest rates on our outstanding short term bank loans and long term loans was 5.51% and 6.29%, respectively, and we paid interest expenses of approximately $0.9 million and $0.6 million on our short and long term loans during the three months ended March 31, 2011, respectively. If interest rates on our short and long term loans were to increase by 10% to 6.06% and 6.92%, respectively, our interest expenses would potentially increase by approximately $0.1 million and $60,000, respectively. If interest rates on our short and long term loans were to decrease by 10% to 4.96% and 5.66%, respectively, our interest expenses would potentially decrease by approximately $0.1 million and $60,000, respectively.  In addition, if we were to draw on our line of credit, interest would be a base rate established by the People’s Bank of China on the unpaid principal amount.  We have not used derivative financial instruments to manage our interest rate risk exposure.
 
 
33

 
 
Foreign Currency Risk

We conduct substantially all of our operations in the PRC, and the Renminbi is the national currency in which our operations are conducted. We have not utilized any derivative financial instruments or any other financial instruments, nor do we utilize any derivative commodity instruments in our operations, nor any similar market sensitive instruments.

The exchange rate between the Renminbi and the U.S. dollar is subject to the PRC government’s foreign currency conversion policies, which may change at any time.  The exchange rates at March 31, 2011 and December 31, 2010 were approximately 6.55 and 6.61 Renminbi to 1 U.S. dollar, respectively. The exchange rate is currently permitted to float within a very limited range. However, there remains significant international pressure on the PRC government to adopt a substantial liberalization of its currency policy, which could result in a further and more significant appreciation in the value of the Renminbi against the U.S. dollar.  Any devaluation of the Renminbi against the U.S. dollar would consequently have an adverse effect on our financial performance and asset values when measured in terms of U.S. dollars.  We recognized a foreign currency translation gain (loss) of approximately $2.3 million and $(34,000) for the three month periods ended March 31, 2011 and 2010.  If the exchange rate were to increase by 10% to US$1.00 = RMB7.2, our foreign currency translation loss would potentially decrease by approximately $22.0 million. If the exchange rate were to decrease by 10% to US$1.00 = RMB5.9, our foreign currency translation gain would potentially increase by approximately $26.4 million.

Inflation

In recent years, China has not experienced significant inflation, and thus inflation has not had a material impact on our results of operations. According to the National Bureau of Statistics of China, the change in Consumer Price Index in China was 5.9%, -0.7% and 4.6% in 2008, 2009 and 2010, respectively.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act, as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective.

Management evaluated the effectiveness of our disclosure controls and procedures for the year ended December 31, 2010, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, and identified a material weakness in our internal control over financial reporting, which we view as an integral part of our disclosure controls and procedures. Consequently, our Chief Executive Officer and Chief Financial Officer concluded that our internal control over financial reporting was not effective at December 31, 2010, because we had insufficient accounting personnel with appropriate knowledge of accounting principles generally accepted in the United States, or US GAAP.  We are still in the process of remediating this material weakness, which substantially influenced the conclusion of our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures were not effective as of March 31, 2011.
 
 
34

 
 
Remediation Plan
 
After the identification of the material weakness as of December 31, 2010, we have undertaken or are in the process of undertaking a number of measures to improve our internal controls over financial reporting to address the material weakness.  Management has taken additional steps to ensure the reliability of our financial reporting, including additional internal review, additional Audit Committee review, efforts to remediate historical material weaknesses and significant deficiencies in internal control over financial reporting, and the performance of additional procedures by management with respect to our financial statements.  In addition, we have launched a recruitment program to hire additional qualified accounting personnel. We plan to hire additional qualified accounting personnel, as necessary to fulfill our reporting obligations and to reinforce our internal audit function. We have also implemented regular US GAAP accounting and financial reporting training programs for our existing accounting and reporting personnel, including senior financial officers. The costs for such remediation plan cannot yet be quantified but are not likely to be significant. However, we do not expect that our plan will fully remediate the material weakness identified above until at least June 30, 2011, and it may not ensure the adequacy of our internal controls over our financial reporting and processes in the future. If we experience additional material weaknesses and significant deficiencies in our internal controls over financial reporting in the future, investors may lose confidence in our reported financial information, which could lead to a decline in our stock price, limit our ability to access the capital markets in the future, and require us to incur additional costs to further improve our internal control systems and procedures.

Changes in Internal Controls
 
As discussed above in connection with our remediation plans, we have undertaken or are in the process of undertaking a number of measures to improve our internal controls over financial reporting in order to address the material weakness identified as of December 31, 2010.  Except for such measures, there have not been any changes in our internal control over financial reporting for the three months ended March 31, 2011, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
 
35

 

PART II – OTHER INFORMATION

Item 5.  Other Information

Appointment of Chief Financial Officer

Effective May 6, 2011, our Board of Directors appointed Mr. Liu Hua, age 38, as our Chief Financial Officer, to serve at the pleasure of our Board of Directors.

Biographical Information of Chief Financial Officer

Certain biographical and related information regarding Liu Hua is as follows:

Liu Hua has served as our Chief Financial Officer since May 2011, as our Vice Chairman since April 2008, and as our Secretary, our Treasurer and a director since May 2003.  From November 2010 until May 2011, Mr. Liu served as our Acting Chief Financial Officer.  From May 2003 to April 2008, Mr. Liu served as our Chief Financial Officer.  From November 2000 to May 2003, Mr. Liu served as the Financial Officer of Feihe Dairy.  From June 1998 to November 2000, Mr. Liu served as the Chief Executive Officer of Shenzhen Cima Limited, a financial consulting company.  From January 1996 to June 1998, Mr. Liu served as Chief Executive Officer of Shenzhen Jiajing Inc., a trading company.  Mr. Liu received a bachelor’s degree in finance and economics from Xi’an Jiaotong University and from Shenzhen University.

Item 6. Exhibits

           
Incorporated by Reference
 
Exhibit
No.
 
Exhibit Title
 
Filed
Herewith
 
Form
 
Exhibit
No.
 
File No.
 
Filing
Date
 
10.1
 
Redemption Agreement dated February 1, 2011
     
8-K
 
10.1
 
001-32473
 
2/2/2011
 
31.1
 
Certification of Principal Executive Officer pursuant to Rules 13a-14 and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
X
                 
31.2
 
Certification of Principal Financial Officer pursuant to Rules 13a-14 and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
X
                 
32.1
 
Certification of Principal Executive Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
X
                 
32.2
 
Certification of Principal Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
X
                 
 
 
36

 

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
FEIHE INTERNATIONAL, INC.
 
       
Date: May 10, 2011
By:
/s/ Leng You-Bin
 
   
 Leng You-Bin
 
   
Chief Executive Officer and President
 
   
(Principal Executive Officer)
 

 
By:
/s/ Liu Hua
 
   
Liu Hua
 
    Chief Financial Officer  
   
(Principal Accounting and Financial Officer)
 
 
37

 

EXHIBIT INDEX
 
           
Incorporated by Reference
 
Exhibit
No.
 
Exhibit Title
 
Filed
Herewith
 
Form
 
Exhibit
No.
 
File No.
 
Filing
Date
 
10.1
 
Redemption Agreement dated February 1, 2011
     
8-K
 
10.1
 
001-32473
 
2/2/2011
 
31.1
 
Certification of Principal Executive Officer pursuant to Rules 13a-14 and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
X
                 
31.2
 
Certification of Principal Financial Officer pursuant to Rules 13a-14 and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
X
                 
32.1
 
Certification of Principal Executive Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
X
                 
32.2
 
Certification of Principal Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
X